Arti Dhar

2.2k total citations
67 papers, 1.7k citations indexed

About

Arti Dhar is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Arti Dhar has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Clinical Biochemistry. Recurrent topics in Arti Dhar's work include Advanced Glycation End Products research (11 papers), RNA regulation and disease (10 papers) and Nitric Oxide and Endothelin Effects (5 papers). Arti Dhar is often cited by papers focused on Advanced Glycation End Products research (11 papers), RNA regulation and disease (10 papers) and Nitric Oxide and Endothelin Effects (5 papers). Arti Dhar collaborates with scholars based in India, Canada and United States. Arti Dhar's co-authors include Kaushik Desai, Lingyun Wu, Indu Dhar, Audesh Bhat, S D Shukla, Jianghai Liu, Bo Jiang, Ashley Untereiner, Srashti Goyal and Dharmarajan Sriram and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Arti Dhar

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arti Dhar India 21 654 506 369 334 203 67 1.7k
Zongxian Cao United States 23 959 1.5× 262 0.5× 210 0.6× 168 0.5× 265 1.3× 30 2.4k
Junichi Fujii Japan 27 1.2k 1.8× 259 0.5× 171 0.5× 413 1.2× 130 0.6× 42 2.2k
Kazuyoshi Ikeda Japan 25 808 1.2× 1.1k 2.1× 554 1.5× 464 1.4× 247 1.2× 64 2.2k
Benjamin S. Szwergold United States 24 776 1.2× 1.1k 2.3× 811 2.2× 666 2.0× 291 1.4× 57 2.5k
Kou‐Yi Tserng United States 27 1.1k 1.7× 329 0.7× 202 0.5× 521 1.6× 171 0.8× 74 2.4k
Bruno Casetta Italy 24 818 1.3× 335 0.7× 343 0.9× 167 0.5× 92 0.5× 41 1.8k
F. Umeda Japan 17 855 1.3× 434 0.9× 611 1.7× 773 2.3× 106 0.5× 55 2.5k
Sibylle Soboll Germany 26 1.2k 1.9× 399 0.8× 149 0.4× 632 1.9× 179 0.9× 58 2.1k
Antony C. McLellan United Kingdom 11 551 0.8× 1.3k 2.6× 485 1.3× 630 1.9× 325 1.6× 16 1.8k
Yutaka Shoji Japan 26 1.1k 1.7× 627 1.2× 85 0.2× 221 0.7× 303 1.5× 59 2.7k

Countries citing papers authored by Arti Dhar

Since Specialization
Citations

This map shows the geographic impact of Arti Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arti Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arti Dhar more than expected).

Fields of papers citing papers by Arti Dhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arti Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arti Dhar. The network helps show where Arti Dhar may publish in the future.

Co-authorship network of co-authors of Arti Dhar

This figure shows the co-authorship network connecting the top 25 collaborators of Arti Dhar. A scholar is included among the top collaborators of Arti Dhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arti Dhar. Arti Dhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhat, Audesh, Raj K. Pandita, Kenneth S. Ramos, et al.. (2025). A predictive chromatin architecture nexus regulates transcription and DNA damage repair. Journal of Biological Chemistry. 301(3). 108300–108300. 2 indexed citations
2.
Dhar, Arti, et al.. (2025). Nucleobindin‐2 Derived Multifunctional Peptide Nesfatin‐1: Renoprotective Mechanisms and Therapeutic Promise. Journal of Biochemical and Molecular Toxicology. 39(11). e70593–e70593.
3.
Dhar, Arti, et al.. (2024). Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review. Journal of Biochemical and Molecular Toxicology. 38(8). e23795–e23795. 5 indexed citations
4.
Singh, Sameer, et al.. (2024). Co-activation of Mas and pGCA receptors suppresses Endothelin-1-induced endothelial dysfunction via nitric oxide/cGMP system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167110–167110.
5.
Dhar, Arti, et al.. (2023). Implications of Translesion DNA Synthesis Polymerases on Genomic Stability and Human Health. Molecular and Cellular Biology. 43(8). 401–425. 5 indexed citations
6.
Goyal, Srashti, et al.. (2023). Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function. European Journal of Pharmacology. 949. 175720–175720. 14 indexed citations
7.
Singh, Sameer, et al.. (2023). Activation of Mas and pGCA receptor pathways protects renal epithelial cell damage against oxidative-stress-induced injury. Peptides. 162. 170959–170959. 3 indexed citations
8.
Bhat, Audesh, et al.. (2022). Canagliflozin and Dapagliflozin Attenuate Glucolipotoxicity-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Inhibition of Sodium-Glucose Cotransporter-1. ACS Pharmacology & Translational Science. 5(4). 216–225. 16 indexed citations
9.
Goyal, Srashti, et al.. (2021). Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies. Hypertension Research. 44(7). 740–755. 63 indexed citations
10.
Kalra, Jaspreet, et al.. (2019). Selective inhibition of PKR improves vascular inflammation and remodelling in high fructose treated primary vascular smooth muscle cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(3). 165606–165606. 12 indexed citations
11.
12.
Agrawal, S., et al.. (2017). MicroRNAs involvement in renal pathophysiology: A bird's eye view. Indian Journal of Nephrology. 27(5). 337–337. 15 indexed citations
13.
Bhat, Audesh, et al.. (2017). High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells. Biochemical and Biophysical Research Communications. 486(3). 645–651. 17 indexed citations
14.
Dhar, Arti, et al.. (2016). Pharmacological evaluation of novel alagebrium analogs as methylglyoxal scavengers in vitro in cardiac myocytes and in vivo in SD rats. International Journal of Cardiology. 223. 581–589. 7 indexed citations
15.
Dhar, Arti, Indu Dhar, Audesh Bhat, & Kaushik Desai. (2016). Alagebrium attenuates methylglyoxal induced oxidative stress and AGE formation in H9C2 cardiac myocytes. Life Sciences. 146. 8–14. 12 indexed citations
16.
Lakhani, Prit, Audesh Bhat, Lavanya Kondiparthi, et al.. (2015). Protein kinase R and the metabolic syndrome. 1(1). 53–61. 2 indexed citations
17.
Dhar, Arti, Kiran Girdhar, Digvijay Singh, et al.. (2011). Protein Stability and Folding Kinetics in the Nucleus and Endoplasmic Reticulum of Eucaryotic Cells. Biophysical Journal. 101(2). 421–430. 129 indexed citations
18.
Dhar, Arti, Kaushik Desai, & Lingyun Wu. (2009). Alagebrium attenuates acute methylglyoxal‐induced glucose intolerance in Sprague‐Dawley rats. British Journal of Pharmacology. 159(1). 166–175. 81 indexed citations
19.
Dhar, Arti, et al.. (2008). Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism. 57(9). 1211–1220. 64 indexed citations
20.
Dhar, Arti, Ravinder K. Kaundal, & Shyam Sunder Sharma. (2006). Neuroprotective effects of FeTMPyP: A peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacological Research. 54(4). 311–316. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zongxian Cao Breakdown of academic impact, for papers by Junichi Fujii Breakdown of academic impact, for papers by Kazuyoshi Ikeda Breakdown of academic impact, for papers by Benjamin S. Szwergold Breakdown of academic impact, for papers by Kou‐Yi Tserng Breakdown of academic impact, for papers by Bruno Casetta Breakdown of academic impact, for papers by F. Umeda Breakdown of academic impact, for papers by Sibylle Soboll Breakdown of academic impact, for papers by Antony C. McLellan Breakdown of academic impact, for papers by Yutaka Shoji
Rankless by CCL
2026